The Cheung Glutamatergic Regimen as a candidate for primary and secondary prevention of Alzheimer's disease onset
{{output}}
Ketamine's ability to lift mood and spur new synapse growth has put glutamate biology at the center of modern neurotherapeutics. Yet the drug's intravenous route, monitoring requirements, and dissociative effects make it a poor candidate for long-term preven... ...
